ID SCN1A_RAT Reviewed; 2009 AA. AC P04774; DT 13-AUG-1987, integrated into UniProtKB/Swiss-Prot. DT 13-AUG-1987, sequence version 1. DT 24-JAN-2024, entry version 179. DE RecName: Full=Sodium channel protein type 1 subunit alpha; DE AltName: Full=Sodium channel protein brain I subunit alpha; DE AltName: Full=Sodium channel protein type I subunit alpha; DE AltName: Full=Voltage-gated sodium channel subunit alpha Nav1.1; GN Name=Scn1a {ECO:0000312|RGD:69364}; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=3754035; DOI=10.1038/320188a0; RA Noda M., Ikeda T., Kayano T., Suzuki H., Takeshima H., Kurasaki M., RA Takahashi H., Numa S.; RT "Existence of distinct sodium channel messenger RNAs in rat brain."; RL Nature 320:188-192(1986). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=2442385; DOI=10.3109/10799898709054998; RA Noda M., Numa S.; RT "Structure and function of sodium channel."; RL J. Recept. Res. 7:467-497(1987). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 177-253. RC STRAIN=Sprague-Dawley; TISSUE=Brain; RX PubMed=1658739; DOI=10.1093/nar/19.20.5673; RA Sarao R., Gupta S.K., Auld V.J., Dunn R.J.; RT "Developmentally regulated alternative RNA splicing of rat brain sodium RT channel mRNAs."; RL Nucleic Acids Res. 19:5673-5679(1991). RN [4] RP PHOSPHORYLATION AT SER-470; SER-551 AND SER-607. RX PubMed=20131913; DOI=10.1021/pr901171q; RA Berendt F.J., Park K.S., Trimmer J.S.; RT "Multisite phosphorylation of voltage-gated sodium channel alpha subunits RT from rat brain."; RL J. Proteome Res. 9:1976-1984(2010). RN [5] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-523; SER-525; SER-550; RP SER-551 AND SER-730, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE RP ANALYSIS]. RX PubMed=22673903; DOI=10.1038/ncomms1871; RA Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C., RA Olsen J.V.; RT "Quantitative maps of protein phosphorylation sites across 14 different rat RT organs and tissues."; RL Nat. Commun. 3:876-876(2012). RN [6] RP INTERACTION WITH THE CONOTOXIN GVIIJ. RX PubMed=24497506; DOI=10.1073/pnas.1324189111; RA Gajewiak J., Azam L., Imperial J., Walewska A., Green B.R., RA Bandyopadhyay P.K., Raghuraman S., Ueberheide B., Bern M., Zhou H.M., RA Minassian N.A., Hagan R.H., Flinspach M., Liu Y., Bulaj G., Wickenden A.D., RA Olivera B.M., Yoshikami D., Zhang M.M.; RT "A disulfide tether stabilizes the block of sodium channels by the RT conotoxin muO[section sign]-GVIIJ."; RL Proc. Natl. Acad. Sci. U.S.A. 111:2758-2763(2014). CC -!- FUNCTION: Mediates the voltage-dependent sodium ion permeability of CC excitable membranes. Assuming opened or closed conformations in CC response to the voltage difference across the membrane, the protein CC forms a sodium-selective channel through which Na(+) ions may pass in CC accordance with their electrochemical gradient. Plays a key role in CC brain, probably by regulating the moment when neurotransmitters are CC released in neurons. Involved in sensory perception of mechanical pain: CC activation in somatosensory neurons induces pain without neurogenic CC inflammation and produces hypersensitivity to mechanical, but not CC thermal stimuli. {ECO:0000250|UniProtKB:A2APX8}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Na(+)(in) = Na(+)(out); Xref=Rhea:RHEA:34963, CC ChEBI:CHEBI:29101; Evidence={ECO:0000250|UniProtKB:P35498}; CC -!- ACTIVITY REGULATION: Inactivation of this channel is specifically CC inhibited by the spider toxins Hm1a and Hm1b (H.maculata, AC P60992 and CC AC P0DOC5) in somatosensory neurons to elicit acute pain and mechanical CC allodynia. {ECO:0000250|UniProtKB:A2APX8}. CC -!- SUBUNIT: The voltage-sensitive sodium channel consists of an ion CC conducting pore forming alpha-subunit regulated by one or more beta-1 CC (SCN1B), beta-2 (SCN2B), beta-3 (SCN3B) and/or beta-4 (SCN4B). Beta-1 CC (SCN1B) and beta-3 (SCN3B) are non-covalently associated with alpha, CC while beta-2 (SCN2B) and beta-4 (SCN4B) are covalently linked by CC disulfide bonds. Interacts with FGF13. Interacts with TMEM233 (By CC similarity). Interacts with the conotoxin GVIIJ (PubMed:24497506). CC {ECO:0000250|UniProtKB:P04775, ECO:0000250|UniProtKB:P35498, CC ECO:0000269|PubMed:24497506}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P35498}; CC Multi-pass membrane protein {ECO:0000250|UniProtKB:D0E0C2}. CC -!- DOMAIN: The sequence contains 4 internal repeats, each with 5 CC hydrophobic segments (S1, S2, S3, S5, S6) and one positively charged CC segment (S4). Segments S4 are probably the voltage-sensors and are CC characterized by a series of positively charged amino acids at every CC third position. {ECO:0000305}. CC -!- DOMAIN: The S3b-S4 and S1-S2 loops of repeat IV are targeted by CC H.maculata toxins Hm1a and Hm1b, leading to inhibit fast inactivation CC of Nav1.1/SCN1A. Selectivity for H.maculata toxins Hm1a and Hm1b CC depends on S1-S2 loops of repeat IV. {ECO:0000250|UniProtKB:A2APX8}. CC -!- PTM: Phosphorylation at Ser-1516 by PKC in a highly conserved CC cytoplasmic loop slows inactivation of the sodium channel and reduces CC peak sodium currents. {ECO:0000250|UniProtKB:P04775}. CC -!- SIMILARITY: Belongs to the sodium channel (TC 1.A.1.10) family. CC Nav1.1/SCN1A subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X03638; CAA27286.1; -; mRNA. DR EMBL; M22253; AAA79965.1; -; mRNA. DR PIR; A25019; A25019. DR RefSeq; NP_110502.1; NM_030875.1. DR AlphaFoldDB; P04774; -. DR BMRB; P04774; -. DR SMR; P04774; -. DR BioGRID; 249530; 3. DR CORUM; P04774; -. DR STRING; 10116.ENSRNOP00000073986; -. DR BindingDB; P04774; -. DR ChEMBL; CHEMBL4906; -. DR DrugCentral; P04774; -. DR GuidetoPHARMACOLOGY; 578; -. DR GlyCosmos; P04774; 9 sites, No reported glycans. DR GlyGen; P04774; 9 sites. DR iPTMnet; P04774; -. DR PhosphoSitePlus; P04774; -. DR SwissPalm; P04774; -. DR PaxDb; 10116-ENSRNOP00000008026; -. DR ABCD; P04774; 3 sequenced antibodies. DR GeneID; 81574; -. DR KEGG; rno:81574; -. DR UCSC; RGD:69364; rat. DR AGR; RGD:69364; -. DR CTD; 6323; -. DR RGD; 69364; Scn1a. DR eggNOG; KOG2301; Eukaryota. DR InParanoid; P04774; -. DR OrthoDB; 1110761at2759; -. DR PhylomeDB; P04774; -. DR PRO; PR:P04774; -. DR Proteomes; UP000002494; Unplaced. DR GO; GO:0030424; C:axon; ISO:RGD. DR GO; GO:0043194; C:axon initial segment; ISO:RGD. DR GO; GO:0014704; C:intercalated disc; ISO:RGD. DR GO; GO:0016020; C:membrane; ISO:RGD. DR GO; GO:0043025; C:neuronal cell body; ISO:RGD. DR GO; GO:0033268; C:node of Ranvier; ISO:RGD. DR GO; GO:0005886; C:plasma membrane; ISO:RGD. DR GO; GO:0042734; C:presynaptic membrane; IDA:SynGO. DR GO; GO:0034706; C:sodium channel complex; ISO:RGD. DR GO; GO:0030315; C:T-tubule; ISO:RGD. DR GO; GO:0001518; C:voltage-gated sodium channel complex; IDA:RGD. DR GO; GO:0030018; C:Z disc; ISS:BHF-UCL. DR GO; GO:0031402; F:sodium ion binding; IDA:RGD. DR GO; GO:0099508; F:voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential; ISO:RGD. DR GO; GO:0005248; F:voltage-gated sodium channel activity; IDA:RGD. DR GO; GO:0007628; P:adult walking behavior; ISO:RGD. DR GO; GO:0086002; P:cardiac muscle cell action potential involved in contraction; ISO:RGD. DR GO; GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; ISS:UniProtKB. DR GO; GO:0008340; P:determination of adult lifespan; ISO:RGD. DR GO; GO:0051649; P:establishment of localization in cell; ISO:RGD. DR GO; GO:0086010; P:membrane depolarization during action potential; ISS:UniProtKB. DR GO; GO:0021675; P:nerve development; ISO:RGD. DR GO; GO:0050884; P:neuromuscular process controlling posture; ISO:RGD. DR GO; GO:0019228; P:neuronal action potential; IDA:RGD. DR GO; GO:0019227; P:neuronal action potential propagation; ISO:RGD. DR GO; GO:0042391; P:regulation of membrane potential; ISO:RGD. DR GO; GO:0035725; P:sodium ion transmembrane transport; IBA:GO_Central. DR GO; GO:0006814; P:sodium ion transport; ISO:RGD. DR CDD; cd13433; Na_channel_gate; 1. DR Gene3D; 1.10.287.70; -; 4. DR Gene3D; 1.10.238.10; EF-hand; 1. DR Gene3D; 1.20.5.1190; iswi atpase; 1. DR Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 4. DR InterPro; IPR005821; Ion_trans_dom. DR InterPro; IPR008051; Na_channel_a1su. DR InterPro; IPR001696; Na_channel_asu. DR InterPro; IPR044564; Na_chnl_inactivation_gate. DR InterPro; IPR010526; Na_trans_assoc_dom. DR InterPro; IPR024583; Na_trans_cytopl. DR InterPro; IPR043203; VGCC_Ca_Na. DR InterPro; IPR027359; Volt_channel_dom_sf. DR PANTHER; PTHR10037:SF280; SODIUM CHANNEL PROTEIN TYPE 1 SUBUNIT ALPHA; 1. DR PANTHER; PTHR10037; VOLTAGE-GATED CATION CHANNEL CALCIUM AND SODIUM; 1. DR Pfam; PF00520; Ion_trans; 4. DR Pfam; PF06512; Na_trans_assoc; 1. DR Pfam; PF11933; Na_trans_cytopl; 1. DR PRINTS; PR00170; NACHANNEL. DR PRINTS; PR01664; NACHANNEL1. DR SUPFAM; SSF81324; Voltage-gated potassium channels; 4. PE 1: Evidence at protein level; KW Cell membrane; Disulfide bond; Glycoprotein; Ion channel; Ion transport; KW Membrane; Phosphoprotein; Reference proteome; Repeat; Sodium; KW Sodium channel; Sodium transport; Transmembrane; Transmembrane helix; KW Transport; Voltage-gated channel. FT CHAIN 1..2009 FT /note="Sodium channel protein type 1 subunit alpha" FT /id="PRO_0000048490" FT TOPO_DOM 1..128 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 129..147 FT /note="Helical; Name=S1 of repeat I" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 148..154 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 155..175 FT /note="Helical; Name=S2 of repeat I" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 176..189 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 190..207 FT /note="Helical; Name=S3 of repeat I" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 208..213 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 214..230 FT /note="Helical; Name=S4 of repeat I" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 231..249 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 250..269 FT /note="Helical; Name=S5 of repeat I" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 270..367 FT /note="Extracellular" FT /evidence="ECO:0000305" FT INTRAMEM 368..392 FT /note="Pore-forming" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 393..399 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 400..420 FT /note="Helical; Name=S6 of repeat I" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 421..768 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 769..787 FT /note="Helical; Name=S1 of repeat II" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 788..798 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 799..818 FT /note="Helical; Name=S2 of repeat II" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 819..832 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 833..852 FT /note="Helical; Name=S3 of repeat II" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 853..854 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 855..872 FT /note="Helical; Name=S4 of repeat II" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 873..888 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 889..907 FT /note="Helical; Name=S5 of repeat II" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 908..936 FT /note="Extracellular" FT /evidence="ECO:0000305" FT INTRAMEM 937..957 FT /note="Pore-forming" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 958..970 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 971..991 FT /note="Helical; Name=S6 of repeat II" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 992..1219 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 1220..1237 FT /note="Helical; Name=S1 of repeat III" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 1238..1250 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 1251..1269 FT /note="Helical; Name=S2 of repeat III" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 1270..1283 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 1284..1302 FT /note="Helical; Name=S3 of repeat III" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 1303..1310 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 1311..1329 FT /note="Helical; Name=S4 of repeat III" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 1330..1346 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 1347..1366 FT /note="Helical; Name=S5 of repeat III" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 1367..1418 FT /note="Extracellular" FT /evidence="ECO:0000305" FT INTRAMEM 1419..1440 FT /note="Pore-forming" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 1441..1457 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 1458..1479 FT /note="Helical; Name=S6 of repeat III" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 1480..1542 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 1543..1560 FT /note="Helical; Name=S1 of repeat IV" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 1561..1571 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 1572..1590 FT /note="Helical; Name=S2 of repeat IV" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 1591..1602 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 1603..1620 FT /note="Helical; Name=S3 of repeat IV" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 1621..1633 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 1634..1650 FT /note="Helical; Name=S4 of repeat IV" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 1651..1669 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT TRANSMEM 1670..1687 FT /note="Helical; Name=S5 of repeat IV" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 1688..1709 FT /note="Extracellular" FT /evidence="ECO:0000305" FT INTRAMEM 1710..1732 FT /note="Pore-forming" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 1733..1762 FT /note="Extracellular" FT /evidence="ECO:0000305" FT TRANSMEM 1763..1785 FT /note="Helical; Name=S6 of repeat IV" FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT TOPO_DOM 1786..2009 FT /note="Cytoplasmic" FT /evidence="ECO:0000305" FT REPEAT 110..454 FT /note="I" FT /evidence="ECO:0000305" FT REPEAT 750..1022 FT /note="II" FT /evidence="ECO:0000305" FT REPEAT 1200..1514 FT /note="III" FT /evidence="ECO:0000305" FT REPEAT 1523..1821 FT /note="IV" FT /evidence="ECO:0000305" FT DOMAIN 1915..1944 FT /note="IQ" FT REGION 28..60 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 458..528 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 584..628 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1129..1163 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1561..1571 FT /note="S1-S2 loop of repeat IV" FT /evidence="ECO:0000250|UniProtKB:A2APX8" FT REGION 1619..1636 FT /note="S3b-S4 loop of repeat IV" FT /evidence="ECO:0000250|UniProtKB:A2APX8" FT REGION 1986..2009 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 28..52 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 506..528 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 584..620 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1990..2009 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 470 FT /note="Phosphoserine" FT /evidence="ECO:0000269|PubMed:20131913" FT MOD_RES 523 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:22673903" FT MOD_RES 525 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:22673903" FT MOD_RES 550 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:22673903" FT MOD_RES 551 FT /note="Phosphoserine" FT /evidence="ECO:0000269|PubMed:20131913, FT ECO:0007744|PubMed:22673903" FT MOD_RES 607 FT /note="Phosphoserine" FT /evidence="ECO:0000269|PubMed:20131913" FT MOD_RES 730 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:22673903" FT MOD_RES 1516 FT /note="Phosphoserine; by PKC" FT /evidence="ECO:0000250|UniProtKB:P04775" FT CARBOHYD 211 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 284 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 295 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 301 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 306 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 338 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1378 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1392 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1403 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 277..345 FT /evidence="ECO:0000250|UniProtKB:D0E0C2" FT DISULFID 919 FT /note="Interchain; with SCN2B or SCN4B" FT /evidence="ECO:0000250|UniProtKB:P04775" FT DISULFID 919 FT /note="Interchain; with the conotoxin GVIIJ (when the FT channel is not linked to SCN2B or SCN4B; the bond to SCN2B FT or SCN4B protects the channel from the inhibition by FT toxin)" FT /evidence="ECO:0000250|UniProtKB:P04775" FT DISULFID 959..968 FT /evidence="ECO:0000250|UniProtKB:D0E0C2" SQ SEQUENCE 2009 AA; 228770 MW; 6808466F6368373B CRC64; MEQTVLVPPG PDSFNFFTRE SLAAIERRIA EEKAKNPKPD KKDDDENGPK PNSDLEAGKN LPFIYGDIPP EMVSEPLEDL DPYYINKKTF IVLNKGKAIF RFSATSALYI LTPFNPLRKI AIKILVHSLF SMLIMCTILT NCVFMTMSNP PDWTKNVEYT FTGIYTFESL IKIIARGFCL EDFTFLRDPW NWLDFTVITF AYVTEFVDLG NVSALRTFRV LRALKTISVI PGLKTIVGAL IQSVKKLSDV MILTVFCLSV FALIGLQLFM GNLRNKCVQW PPTNASLEEH SIEKNVTTDY NGTLVNETVF EFDWKSYIQD SRYHYFLEGV LDALLCGNSS DAGQCPEGYM CVKAGRNPNY GYTSFDTFSW AFLSLFRLMT QDFWENLYQL TLRAAGKTYM IFFVLVIFLG SFYLINLILA VVAMAYEEQN QATLEEAEQK EAEFQQMLEQ LKKQQEAAQQ AAAATASEHS REPSAAGRLS DSSSEASKLS SKSAKERRNR RKKRKQKEQS GGEEKDDDEF HKSESEDSIR RKGFRFSIEG NRLTYEKRYS SPHQSLLSIR GSLFSPRRNS RTSLFSFRGR AKDVGSENDF ADDEHSTFED NESRRDSLFV PRRHGERRNS NLSQTSRSSR MLAGLPANGK MHSTVDCNGV VSLVGGPSVP TSPVGQLLPE VIIDKPATDD NGTTTETEMR KRRSSSFHVS MDFLEDPSQR QRAMSIASIL TNTVEELEES RQKCPPCWYK FSNIFLIWDC SPYWLKVKHI VNLVVMDPFV DLAITICIVL NTLFMAMEHY PMTEHFNHVL TVGNLVFTGI FTAEMFLKII AMDPYYYFQE GWNIFDGFIV TLSLVELGLA NVEGLSVLRS FRLLRVFKLA KSWPTLNMLI KIIGNSVGAL GNLTLVLAII VFIFAVVGMQ LFGKSYKDCV CKIATDCKLP RWHMNDFFHS FLIVFRVLCG EWIETMWDCM EVAGQAMCLT VFMMVMVIRN LVVLNLFLAL LLSSFSADNL AATDDDNEMN NLQIAVDRMH KGVAYVKRKI YEFIQQSFVR KQKILDEIKP LDDLNNRKDN CTSNHTTEIG KDLDCLKDVN GTTSGIGTGS SVEKYIIDES DYMSFINNPS LTVTVPIAVG ESDFENLNTE DFSSESDLEE SKEKLNESSS SSEGSTVDIG APAEEQPVME PEETLEPEAC FTEGCVQRFK CCQISVEEGR GKQWWNLRRT CFRIVEHNWF ETFIVFMILL SSGALAFEDI YIDQRKTIKT MLEYADKVFT YIFILEMLLK WVAYGYQTYF TNAWCWLDFL IVDVSLVSLT ANALGYSELG AIKSLRTLRA LRPLRALSRF EGMRVVVNAL LGAIPSIMNV LLVCLIFWLI FSIMGVNLFA GKFYHCVNTT TGDTFEITEV NNHSDCLKLI ERNETARWKN VKVNFDNVGF GYLSLLQVAT FKGWMDIMYA AVDSRNVELQ PKYEESLYMY LYFVIFIIFG SFFTLNLFIG VIIDNFNQQK KKFGGQDIFM TEEQKKYYNA MKKLGSKKPQ KPIPRPGNKF QGMVFDFVTR QVFDISIMIL ICLNMVTMMV ETDDQSDYVT SILSRINLVF IVLFTGECVL KLISLRHYYF TIGWNIFDFV VVILSIVGMF LAELIEKYFV SPTLFRVIRL ARIGRILRLI KGAKGIRTLL FALMMSLPAL FNIGLLLFLV MFIYAIFGMS NFAYVKREVG IDDMFNFETF GNSMICLFQI TTSAGWDGLL APILNSKPPD CDPNKVNPGS SVKGDCGNPS VGIFFFVSYI IISFLVVVNM YIAVILENFS VATEESAEPL SEDDFEMFYE VWEKFDPDAT QFMEFEKLSQ FAAALEPPLN LPQPNKLQLI AMDLPMVSGD RIHCLDILFA FTKRVLGESG EMDALRIQME ERFMASNPSK VSYQPITTTL KRKQEEVSAV IIQRAYRRHL LKRTVKQASF TYNKNKLKGG ANLLVKEDMI IDRINENSIT EKTDLTMSTA ACPPSYDRVT KPIVEKHEQE GKDEKAKGK //